Mediana invests in KF94 mask production facilities... Production starts in June View original image

[Asia Economy Reporter Eunmo Koo] Mediana is investing in mask production facilities to respond to infectious diseases such as the novel coronavirus disease (COVID-19).


Mediana, a global specialist in patient monitoring devices, defibrillators, and body composition analyzers, announced on the 24th that it has decided to invest in KF94 mask production facilities to normalize mask supply. The company stated, "We have been working with equipment manufacturers to establish production facilities for several months," adding, "The mask production facilities will feature a fully automated system including a series of production processes and individual packaging, enabling a monthly average production capacity of 1 million masks and a maximum of 2 million masks starting from June."



A company representative explained, "Mask-wearing has become a daily routine due to infectious diseases like COVID-19 that occur periodically, as well as fine dust and yellow dust, so the demand for masks will continue steadily," and added, "In addition, we have applied for a defense venture project to develop firefighting masks and military gas masks."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing